Healthcare Sales & Marketing Network News: Ciprofloxacin

Searching News Database: Ciprofloxacin

HSMN NewsFeed - 21 Mar 2022
NeuroSense Therapeutics Receives FDA Clearance of IND for PrimeC for the Treatment of ALS
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 30 Jun 2021
Mitsubishi Tanabe Pharma America Announces EXSERVAN(TM) (riluzole) is Now Available in the U.S. for the Treatment of ALS
Biopharmaceuticals Neurology Product Launch

HSMN NewsFeed - 19 Nov 2018
FDA Approves AEMCOLO(TM) (rifamycin), the First Antibiotic Approved for the Treatment of Travelers' Diarrhea in Over a Decade
Biopharmaceuticals FDA Product Launch

HSMN NewsFeed - 20 May 2016
Otonomy Announces Assignment of C Code and Pass-Through Payment Status for OTIPRIO(TM)
Biopharmaceuticals Reimbursement

HSMN NewsFeed - 26 Jan 2016
Otonomy Announces Publication Supporting Development of OTO-104 as Protectant Against Cisplatin-Induced Hearing Loss
Biopharmaceuticals Oncology

HSMN NewsFeed - 11 Dec 2015
Otonomy Announces FDA Approval of OTIPRIO(TM) for the Treatment of Pediatric Patients Undergoing Tympanostomy Tube Placement Surgery
Biopharmaceuticals FDA

HSMN NewsFeed - 30 Nov 2015
OticPharma Appoints Keith A. Katkin as Chairman of the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Nov 2015
OticPharma Appoints Dr. Catherine C. Turkel as Chief Development Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Sep 2015
OticPharma Announces Key Additions to the Senior Management Team
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 16 Sep 2014
Synereca Pharmaceuticals Announces Financing Led by Accele Venture Partners
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 20 May 2014
Spero Therapeutics Appoints Thomas Parr, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Aug 2013
Grifols and Aradigm Corporation Complete the Closing of Worldwide Licensing Agreement to Develop and Commercialize Pulmaquin(R)
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 3 Mar 2011
InterMune Receives European Union Approval for Esbriet(R) (pirfenidone)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 14 Feb 2011
Optimer Pharmaceuticals Appoints Glenn Tillotson, Ph.D., to Senior Vice President of Medical Affairs and Announces Executive Promotions
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Sep 2010
Aradigm Presents Results Supporting Once-Daily Dosing With Its Inhaled Liposomal Ciprofloxacin Formulations at the 2010 European Respiratory Society (ERS) Annual Congress
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 11 Mar 2010
FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 26 Jan 2010
Prometheus Acquires Exclusive Rights to PROLEUKIN(R) (aldesleukin) in the U.S.
Biopharmaceuticals Oncology Acquisitions

HSMN NewsFeed - 1 Jun 2009
Depomed Names Shay Weisbrich Vice President of Marketing
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 2 Feb 2009
Federal Trade Commission Files Complaint Against Par Pharmaceutical Over Court-Approved AndroGel(R) Litigation Settlement
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 5 Jan 2009
Depomed Announces Management Promotions
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 Dec 2008
Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million
Biopharmaceuticals Drug Delivery Acquisitions

HSMN NewsFeed - 21 Oct 2008
Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 22 Aug 2008
Cymbalta Receives European Approval for the Treatment of Generalised Anxiety Disorder
Biopharmaceuticals Regulatory

HSMN NewsFeed - 23 Jul 2008
Depomed's ProQuin(R) XR Achieves First Marketing Authorization in Europe
Biopharmaceuticals Regulatory

HSMN NewsFeed - 22 Jul 2008
Santarus and Depomed Announce U.S. Promotion Agreement for GLUMETZA Prescription Products
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 27 Jun 2008
European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder
Biopharmaceuticals Regulatory

HSMN NewsFeed - 24 Mar 2008
Depomed Doses First Patient in New Phase 3 Clinical Trial of Gabapentin GR in Postherpetic Neuralgia
Biopharmaceuticals

HSMN NewsFeed - 20 Feb 2008
Depomed Names Abid Rawn Vice President of Sales and Marketing
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Jan 2008
Depomed Receives FDA Approval for 1000 mg Strength Tablets of Glumetza
Biopharmaceuticals FDA Endocrinology Drug Delivery

HSMN NewsFeed - 3 Dec 2007
Depomed Names Michael Sweeney Vice President of Product Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Oct 2007
Depomed and King Pharmaceuticals Terminate Promotion Agreement for GLUMETZA(TM)
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 11 Oct 2007
Depomed Announces Retirement of Chief Financial Officer John F. Hamilton
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Sep 2007
Depomed and Watson Expand ProQuin(R) XR Promotion Agreement to Include Ob/Gyn Field
Biopharmaceuticals

HSMN NewsFeed - 17 Sep 2007
FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
Biopharmaceuticals Urology FDA

HSMN NewsFeed - 17 Sep 2007
Depomed Announces Reduction in Force
Biopharmaceuticals

HSMN NewsFeed - 27 Aug 2007
Dr. John Fara Retires as Chairman, President and CEO of Depomed; Mr. Carl Pelzel Appointed President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Aug 2007
Bayer HealthCare and Nektar Therapeutics Launch Global Development and Commercialization Agreement to Fight Gram-Negative Pneumonias
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 10 Jul 2007
Depomed Announces Results of Phase 3 Clinical Trial for Gabapentin GR(TM) In Postherpetic Neuralgia
Biopharmaceuticals

HSMN NewsFeed - 5 Jul 2007
Depomed Reacquires the Rights to ProQuin(R) XR
Biopharmaceuticals Acquisitions Licensing

HSMN NewsFeed - 8 Jun 2007
International Movement Disorder Specialists Receive New Information About the Use of Once-Daily AZILECT(R) in the Treatment of Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 19 May 2007
Five Days of LEVAQUIN(R) as Effective as 10 Days of Ciprofloxacin in Complicated Urinary Tract Infections and Acute Pyelonephritis
Biopharmaceuticals Urology

HSMN NewsFeed - 11 Apr 2007
Advanced Magnetics Announces Positive Results from Two Additional Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement Therapeutic
Biopharmaceuticals

HSMN NewsFeed - 2 Apr 2007
Depomed Files Prior Approval Supplement for 1000 mg Strength Tablets of Glumetza
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 26 Mar 2007
Mylan Announces Another First to Market With the Launch of Ciprofloxacin Extended-Release Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 12 Mar 2007
Depomed Files Investigational New Drug Application for Gabapentin GR for the Treatment of Postmenopausal Hot Flashes
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 12 Feb 2007
Depomed and Biovail Sign License Agreement for AcuForm(TM) Drug Delivery Technology
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 16 Jan 2007
Aradigm Receives FDA Orphan Drug Designation for Liposomal Ciprofloxacin for Bronchiectasis
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Dec 2006
Largest Disease Modification Trial for Parkinson's Disease Completes Enrollment
Biopharmaceuticals Neurology

HSMN NewsFeed - 21 Dec 2006
Depomed Receives $10 Million License Fee from Esprit and Withdraws Arbitration Proceeding
Biopharmaceuticals Licensing Litigation

HSMN NewsFeed - 20 Dec 2006
Depomed Announces Sweeping Interim Victory in Litigation against Ivax
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 18 Dec 2006
Depomed Delivers Notice of Breach and Demand for Arbitration to Esprit Pharma
Biopharmaceuticals Drug Delivery Litigation

HSMN NewsFeed - 17 Nov 2006
AMDL Announces Launch of Antibiotic Levofloxacin in China
Biopharmaceuticals Regulatory

HSMN NewsFeed - 23 Oct 2006
Salix Pharmaceuticals Reports American College of Gastroenterology Update
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 18 Oct 2006
Depomed Obtains Exclusive License to Gabapentin Use in Hot Flashes
Biopharmaceuticals Licensing

HSMN NewsFeed - 12 Jul 2006
Teva Will Be Sole Promoter of AZILECT(R) for Parkinson's Disease in the United States
Biopharmaceuticals Neurology

HSMN NewsFeed - 6 Jul 2006
Depomed Names Matthew Gosling Vice President, Legal and General Counsel
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Jul 2006
Aradigm and Novo Nordisk Execute Further Restructuring of Partnership
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 28 Jun 2006
King Pharmaceuticals and Depomed Announce Agreement to Co-Promote Glumetza(TM)
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 17 May 2006
AZILECT(R) FDA Approval Brings New Hope to People Living With Parkinson's Disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 17 May 2006
Teva Announces FDA Grants Approval of AZILECT(R) (Rasagiline) for Parkinson's Disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 10 May 2006
Depomed Finalizes Phase III Clinical Trial Protocol for Gabapentin GR(TM)
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 9 May 2006
Aradigm Receives FDA Orphan Drug Designation of Liposomal Ciprofloxacin for Cystic Fibrosis
Biopharmaceuticals FDA

Return to NewsFeed

Additional items found! 93

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 93 additional stories matching:
Ciprofloxacin
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.